SOPHiA GENETICS SA
SOPH Nasdaq Services-Computer Processing & Data Preparation Financials FY2019โFY2025
Last close ยท Oct 23, 2026
$7.35
4.3%
Revenue
Total sales reported in the income statement.
$77.3M
18.6%
vs prior year
Operating margin
Operating income as a share of revenue.
โ91.8%
10.4ย pts
Net income
Profit after all expenses, interest and tax.
โ$79.0M
Free cash flow
Cash from operations minus capital spending.
โ$36.5M
Return on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
โ227.8%
49.5ย pts
Market cap
Last close times the latest diluted share count, so it is approximate.
$496M
Oct 23 close
P/E
Last close divided by diluted earnings per share over the last four quarters.
โ
On โ$1.17 EPS (TTM)
What SOPHiA GENETICS SA does
No business description yet.
- Legal name
- SOPHiA GENETICS SA
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 20-F ยท Mar 3, 2026
- Accession ยท CIK
- 0001840706-26-000006
0001840706
Revenue and margins
SOPHiA GENETICS SA had $77.3M of revenue in fiscal 2025, up 18.6% on the year before.
FY19
Revenue $25.4M
FY20
Revenue $28.4M
FY21
Revenue $40.5M
FY22
Revenue $47.6M
FY23
Revenue $62.4M
FY24
Revenue $65.2M
FY25
Revenue $77.3M
Q2 '22
Revenue $11.7M
Q2 '23
Revenue $15.1M
Q2 '24
Revenue $15.8M
Q2 '25
Revenue $18.3M
FY19
Gross 70.3%
Operating โ
Net โ133.2%
FCF โ130.3%
FY20
Gross 62.3%
Operating โ131.6%
Net โ138.5%
FCF โ113.3%
FY21
Gross 62.4%
Operating โ176.7%
Net โ182.1%
FCF โ149.9%
FY22
Gross 65.7%
Operating โ184.7%
Net โ183.9%
FCF โ156.0%
FY23
Gross 68.8%
Operating โ120.0%
Net โ126.6%
FCF โ87.7%
FY24
Gross 67.4%
Operating โ102.1%
Net โ95.9%
FCF โ68.7%
FY25
Gross 67.4%
Operating โ91.8%
Net โ102.2%
FCF โ47.2%
Gross
Operating
Net
FCF
Q2 '22
Gross 65.3%
Operating โ206.4%
Net โ211.5%
FCF โ
Q2 '23
Gross 66.7%
Operating โ133.2%
Net โ142.1%
FCF โ
Q2 '24
Gross 68.2%
Operating โ94.9%
Net โ96.1%
FCF โ
Q2 '25
Gross 67.0%
Operating โ100.9%
Net โ122.3%
FCF โ
Gross
Operating
Net
FCF
Net income and earnings per share
Loss periods are shown in red.
FY19
Net income โ$33.8M
FY20
Net income โ$39.3M
FY21
Net income โ$73.7M
FY22
Net income โ$87.4M
FY23
Net income โ$79.0M
FY24
Net income โ$62.5M
FY25
Net income โ$79.0M
Q2 '22
Net income โ$24.7M
Q2 '23
Net income โ$21.4M
Q2 '24
Net income โ$15.2M
Q2 '25
Net income โ$22.4M
FY19
Diluted EPS โ
FY20
Diluted EPS โ$0.93
FY21
Diluted EPS โ$1.33
FY22
Diluted EPS โ$1.36
FY23
Diluted EPS โ$1.22
FY24
Diluted EPS โ$0.95
FY25
Diluted EPS โ$1.17
Q2 '22
Diluted EPS โ$0.39
Q2 '23
Diluted EPS โ$0.33
Q2 '24
Diluted EPS โ$0.23
Q2 '25
Diluted EPS โ$0.33
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
FY19
Return on capital โ
Return on equity โ151.8%
Return on assets โ
FY20
Return on capital โ101.1%
Return on equity โ64.1%
Return on assets โ29.8%
FY21
Return on capital โ68.5%
Return on equity โ39.2%
Return on assets โ32.6%
FY22
Return on capital โ
Return on equity โ36.8%
Return on assets โ31.0%
FY23
Return on capital โ209.7%
Return on equity โ44.9%
Return on assets โ35.1%
FY24
Return on capital โ178.3%
Return on equity โ50.4%
Return on assets โ34.6%
FY25
Return on capital โ227.8%
Return on equity โ110.0%
Return on assets โ49.6%
Return on capital
Return on equity
Return on assets
Cash flow
Free cash flow was โ$36.5M in fiscal 2025, โ47.2% of revenue. Cash from operations minus capital spending.
FY19
Free cash flow โ$33.0M
FY20
Free cash flow โ$32.2M
FY21
Free cash flow โ$60.6M
FY22
Free cash flow โ$74.2M
FY23
Free cash flow โ$54.7M
FY24
Free cash flow โ$44.8M
FY25
Free cash flow โ$36.5M
FY19
Cash from operations โ$31.7M
Capital spending $1.4M
FY20
Cash from operations โ$31.7M
Capital spending $0.5M
FY21
Cash from operations โ$57.9M
Capital spending $2.7M
FY22
Cash from operations โ$70.1M
Capital spending $4.1M
FY23
Cash from operations โ$53.2M
Capital spending $1.5M
FY24
Cash from operations โ$44.5M
Capital spending $0.2M
FY25
Cash from operations โ$35.9M
Capital spending $0.6M
Cash from operations
Capital spending
Dividends, buybacks and share count
SOPHiA GENETICS SA returned โ to shareholders in fiscal 2025. The diluted share count rose 2.2%.
FY19
Dividends โ
Buybacks โ
FY20
Dividends โ
Buybacks โ
FY21
Dividends โ
Buybacks โ
FY22
Dividends โ
Buybacks โ
FY23
Dividends โ
Buybacks โ
FY24
Dividends โ
Buybacks โ
FY25
Dividends โ
Buybacks โ
Dividends
Buybacks
FY19
Diluted shares โ
FY20
Diluted shares 0.04B
FY21
Diluted shares 0.06B
FY22
Diluted shares 0.06B
FY23
Diluted shares 0.06B
FY24
Diluted shares 0.07B
FY25
Diluted shares 0.07B
Balance sheet
Cash, debt and the ratios that show how comfortably SOPHiA GENETICS SA can carry it.
FY19
Cash $18.1M
Debt $3.8M
FY20
Cash $74.6M
Debt $3.3M
FY21
Cash $193M
Debt $0.0M
FY22
Cash $161M
Debt โ
FY23
Cash $123M
Debt $0.0M
FY24
Cash $80.2M
Debt $13.2M
FY25
Cash $70.3M
Debt $47.7M
Cash
Debt
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $193M | $161M | $123M | $80.2M | $70.3M |
| Debt incl. finance leases | $0.0M | โ | $0.0M | $13.2M | $47.7M |
| Debt / equity | 0.0x | โ | 0.0x | 0.1x | 1.0x |
| Interest coverage | โ108.6x | โ137.4x | โ127.3x | โ34.8x | โ15.6x |
| Current ratio | 9.9x | 7.3x | 4.2x | 3.7x | 2.0x |
| Quick ratio | 9.7x | 7.1x | 4.0x | 3.5x | 1.8x |
| Total assets | $320M | $244M | $206M | $155M | $163M |
| Total liabilities | $44.8M | $43.7M | $54.7M | $58.8M | $116M |
| Shareholders' equity | $275M | $200M | $151M | $96.5M | $47.1M |
| Net debt (โ = net cash) | โ$193M | โ | โ$123M | โ$67.0M | โ$22.6M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. โPlanโ marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
โ
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8โ9 is strong, 0โ2 weak.
| Test | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|
| Net income is positive | โ | โ | โ | โ | โ | โ | โ |
| Cash from operations is positive | โ | โ | โ | โ | โ | โ | โ |
| Return on assets rose | โ | โ | โ | โ | โ | โ | โ |
| Cash from operations exceeds net income | โ | โ | โ | โ | โ | โ | โ |
| Debt fell relative to assets | โ | โ | โ | โ | โ | โ | โ |
| Current ratio rose | โ | โ | โ | โ | โ | โ | โ |
| Share count didn't rise | โ | โ | โ | โ | โ | โ | โ |
| Gross margin rose | โ | โ | โ | โ | โ | โ | โ |
| Revenue rose relative to assets | โ | โ | โ | โ | โ | โ | โ |
| F-score | โ / 3 | โ / 4 | 5 / 9 | 3 / 8 | 3 / 8 | 2 / 9 | 2 / 9 |
| Accruals ratio | โ | โ5.8% | โ7.0% | โ6.2% | โ11.4% | โ9.9% | โ27.1% |
| Altman Z'' | โ | 2.42 | 8.02 | 2.95 | โ1.93 | โ7.33 | โ10.93 |
7 years of figures
Amounts in USD. Hover a ratioโs name for its definition.
| Fiscal year | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | $25.4M | $28.4M | $40.5M | $47.6M | $62.4M | $65.2M | $77.3M |
| Net interest income | $0.1M | $0.1M | โ$0.6M | $0.7M | $4.0M | โ | โ |
| Gross profit | $17.8M | $17.7M | $25.2M | $31.3M | $42.9M | $43.9M | $52.1M |
| Research and development | $15.0M | $18.6M | $26.6M | $35.4M | $37.0M | $34.4M | $34.2M |
| Operating income | โ | โ$37.4M | โ$71.5M | โ$87.8M | โ$74.8M | โ$66.6M | โ$70.9M |
| Interest expense | $1.0M | $0.8M | $0.7M | $0.6M | $0.6M | $1.9M | $4.6M |
| Pretax income | โ$33.6M | โ$41.2M | โ$73.5M | โ$87.6M | โ$78.5M | โ$61.3M | โ$77.5M |
| Income tax | $0.2M | โ$1.9M | $0.2M | โ$0.1M | $0.5M | $1.2M | $1.5M |
| Net income | โ$33.8M | โ$39.3M | โ$73.7M | โ$87.4M | โ$79.0M | โ$62.5M | โ$79.0M |
| Net income to common | โ$33.8M | โ$39.3M | โ$73.7M | โ$87.4M | โ$79.0M | โ$62.5M | โ$79.0M |
| Diluted EPS | โ | โ$0.93 | โ$1.33 | โ$1.36 | โ$1.22 | โ$0.95 | โ$1.17 |
| Diluted shares | โ | 0.04B | 0.06B | 0.06B | 0.06B | 0.07B | 0.07B |
| Cash flow | |||||||
| Cash from operations | โ$31.7M | โ$31.7M | โ$57.9M | โ$70.1M | โ$53.2M | โ$44.5M | โ$35.9M |
| Capital expenditure | $1.4M | $0.5M | $2.7M | $4.1M | $1.5M | $0.2M | $0.6M |
| Free cash flow | โ$33.0M | โ$32.2M | โ$60.6M | โ$74.2M | โ$54.7M | โ$44.8M | โ$36.5M |
| Stock-based compensation | $0.7M | $1.4M | $8.5M | $13.6M | $15.2M | $16.5M | $16.2M |
| Balance sheet | |||||||
| Cash and short-term investments | $18.1M | $74.6M | $193M | $161M | $123M | $80.2M | $70.3M |
| Total debt | $3.8M | $3.3M | $0.0M | โ | $0.0M | $13.2M | $47.7M |
| Current assets | โ | $110M | $283M | $196M | $148M | $99.4M | $99.1M |
| Current liabilities | โ | $21.6M | $28.6M | $26.8M | $35.6M | $26.8M | $50.5M |
| Inventory | โ | $3.4M | $5.7M | $5.2M | $6.5M | $5.9M | $6.4M |
| Property and equipment, net | โ | $1.8M | $4.7M | $7.1M | $7.5M | $5.2M | $5.7M |
| Intangible assets | โ | $13.3M | $15.7M | $20.0M | $27.2M | $29.0M | $35.9M |
| Total assets | โ | $132M | $320M | $244M | $206M | $155M | $163M |
| Total liabilities | โ | $31.6M | $44.8M | $43.7M | $54.7M | $58.8M | $116M |
| Shareholders' equity | $22.3M | $101M | $275M | $200M | $151M | $96.5M | $47.1M |
| Margins | |||||||
| Gross margin | 70.3% | 62.3% | 62.4% | 65.7% | 68.8% | 67.4% | 67.4% |
| Operating margin | โ | โ131.6% | โ176.7% | โ184.7% | โ120.0% | โ102.1% | โ91.8% |
| Net margin | โ133.2% | โ138.5% | โ182.1% | โ183.9% | โ126.6% | โ95.9% | โ102.2% |
| FCF margin | โ130.3% | โ113.3% | โ149.9% | โ156.0% | โ87.7% | โ68.7% | โ47.2% |
| Net interest share of revenue | 0.3% | 0.3% | โ1.6% | 1.4% | 6.3% | โ | โ |
| Returns | |||||||
| Return on capital | โ | โ101.1% | โ68.5% | โ | โ209.7% | โ178.3% | โ227.8% |
| Return on capital employed | โ | โ33.8% | โ24.5% | โ40.5% | โ43.9% | โ51.8% | โ63.0% |
| Return on equity | โ151.8% | โ64.1% | โ39.2% | โ36.8% | โ44.9% | โ50.4% | โ110.0% |
| Return on assets | โ | โ29.8% | โ32.6% | โ31.0% | โ35.1% | โ34.6% | โ49.6% |
| Return on tangible equity | โ151.8% | โ45.1% | โ28.4% | โ48.5% | โ63.6% | โ92.6% | โ702.0% |
| Growth | |||||||
| Revenue growth | โ | 12.0% | 42.4% | 17.6% | 31.1% | 4.5% | 18.6% |
| Share count change | โ | โ | 30.6% | 15.9% | 1.0% | 2.0% | 2.2% |
| Financial health | |||||||
| Debt / equity | 0.2x | 0.0x | 0.0x | โ | 0.0x | 0.1x | 1.0x |
| Interest coverage | โ | โ44.5x | โ108.6x | โ137.4x | โ127.3x | โ34.8x | โ15.6x |
| Current ratio | โ | 5.1x | 9.9x | 7.3x | 4.2x | 3.7x | 2.0x |
| Quick ratio | โ | 4.9x | 9.7x | 7.1x | 4.0x | 3.5x | 1.8x |
| Capital allocation | |||||||
| Capex / revenue | 5.3% | 1.6% | 6.6% | 8.6% | 2.4% | 0.4% | 0.7% |
| Stock comp / revenue | 2.8% | 4.8% | 21.0% | 28.6% | 24.4% | 25.3% | 21.0% |
| Quality scores | |||||||
| Piotroski F-score | โ | โ | 5.0 | 3.0 | 3.0 | 2.0 | 2.0 |
| Altman Z'' | โ | 2.4 | 8.0 | 3.0 | โ1.9 | โ7.3 | โ10.9 |
| Accruals ratio | โ | โ5.8% | โ7.0% | โ6.2% | โ11.4% | โ9.9% | โ27.1% |
Source: SEC EDGAR XBRL filings (CIK 0001840706). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only โ not investment advice. Check the original filings before relying on any figure.